MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $116,259,000 | -64.1% | 1,368,720 | -78.8% | 0.83% | -68.0% |
| Q3 2019 | $323,420,000 | +90.8% | 6,468,402 | +39.2% | 2.59% | +103.0% |
| Q2 2019 | $169,476,000 | +14.6% | 4,647,008 | -12.2% | 1.28% | +13.4% |
| Q1 2019 | $147,869,000 | +67.8% | 5,290,481 | +14.9% | 1.12% | +49.6% |
| Q4 2018 | $88,134,000 | -22.2% | 4,604,719 | +21.6% | 0.75% | -5.4% |
| Q3 2018 | $113,275,000 | -5.9% | 3,787,211 | +15.4% | 0.80% | -11.6% |
| Q2 2018 | $120,419,000 | +20.7% | 3,281,183 | +8.3% | 0.90% | +16.9% |
| Q1 2018 | $99,795,000 | +25.7% | 3,029,611 | +4.3% | 0.77% | +26.7% |
| Q4 2017 | $79,408,000 | -13.4% | 2,904,475 | +17.3% | 0.61% | -13.9% |
| Q3 2017 | $91,740,000 | +18.8% | 2,476,778 | +21.9% | 0.70% | +7.1% |
| Q2 2017 | $77,212,000 | +713.9% | 2,031,359 | +947.1% | 0.66% | +712.3% |
| Q1 2017 | $9,487,000 | +2416.4% | 194,000 | +1047.9% | 0.08% | +3950.0% |
| Q3 2014 | $377,000 | -41.6% | 16,900 | -23.9% | 0.00% | -50.0% |
| Q2 2014 | $645,000 | – | 22,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |